OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microtubules destabilizing agents binding sites in tubulin
Daniel Alpízar-Pedraza, Ania de la Nuez Veulens, Enrique Colina Araújo, et al.
Journal of Molecular Structure (2022) Vol. 1259, pp. 132723-132723
Closed Access | Times Cited: 21

Showing 21 citing articles:

New insights into the anticancer therapeutic potential of maytansine and its derivatives
Sameen Zafar, Muhammad Armaghan, Khushbukhat Khan, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115039-115039
Open Access | Times Cited: 19

Dual-target inhibitors of colchicine binding site for cancer treatment
Lu Lu, Keke Li, Jiaxin Pu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116543-116543
Closed Access | Times Cited: 5

Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan
Negar Pourjamal, Vadim Le Joncour, György Vereb, et al.
Translational Oncology (2025) Vol. 53, pp. 102284-102284
Open Access

Maytansinoids in cancer therapy: advancements in antibody–drug conjugates and nanotechnology-enhanced drug delivery systems
Matteo Perra, Ines Castangia, Matteo Aroffu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access

Synthesis and biological evaluation of structurally diverse 6-aryl-3-aroyl-indole analogues as inhibitors of tubulin polymerization
Wen Ren, Yuling Deng, J. WARD, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115794-115794
Closed Access | Times Cited: 10

Design, synthesis and evaluation of 4-phenyl-1,2,3-triazole substituted pyrimidine derivatives as antiproliferative and tubulin polymerization inhibitors
Ashish Ranjan Dwivedi, Vijay Kumar, Ravi Prakash Yadav, et al.
Journal of Molecular Structure (2022) Vol. 1267, pp. 133592-133592
Closed Access | Times Cited: 13

Dual Ruthenium-Catalyzed Alkene Isomerization–Hydrogen Auto-Transfer Unlocks Skipped Dienes as Pronucleophiles for Enantioselective Alcohol C–H Allylation
Zachary J. Dubey, Weijia Shen, John A. Little, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 15, pp. 8576-8582
Closed Access | Times Cited: 6

Identification of Novel β-Tubulin Inhibitors Using a Combined In Silico/In Vitro Approach
Mark James Horgan, Lukas Zell, Bianka Siewert, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 20, pp. 6396-6411
Open Access | Times Cited: 5

BP-M345 as a Basis for the Discovery of New Diarylpentanoids with Promising Antimitotic Activity
Joana Moreira, Patrícia Silva, Eliseba Castro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1691-1691
Open Access | Times Cited: 1

Investigating the Promising Anticancer Activity of Cetuximab and Fenbendazole Combination as Dual CBS and VEGFR‐2 Inhibitors and Endowed with Apoptotic Potential
Norhan Eid, Ahmed A. Al‐Karmalawy, Taha M. A. Eldebss, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 4
Closed Access | Times Cited: 1

Modification of the phenyl ring B of phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates by pyridinyl moiety leads to novel antimitotics targeting the colchicine-binding site
Vincent Ouellette, Chahrazed Bouzriba, Atziri Corin Chavez Alvarez, et al.
Bioorganic & Medicinal Chemistry Letters (2024) Vol. 105, pp. 129745-129745
Open Access | Times Cited: 1

Microtubule stabilising peptides: new paradigm towards management of neuronal disorders
Shubhangi Bhargava, Riya Kulkarni, Bhaskar Dewangan, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 11, pp. 2192-2205
Closed Access | Times Cited: 2

Characterization of Intrinsically Disordered Proteins in Healthy and Diseased States by Nuclear Magnetic Resonance
Mohamad Hesam Shahrajabian, Wenli Sun
Reviews on Recent Clinical Trials (2024) Vol. 19, Iss. 3, pp. 176-188
Closed Access

Discovery of novel quinazoline derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potential anti-colon cancer effects
Liqiao Zhu, Mengyu Zhang, Jiafu Leng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 117000-117000
Closed Access

Evaluation of 3,5-Diphenyl-2-Pyrazolines for Antimitotic Activity by Inhibition of Tubulin Polymerization
Soon Young Shin, Euitaek Jung, Young Han Lee, et al.
Journal of Chemistry (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 3

Research progress on antitumor activity of XRP44X and analogues as microtubule targeting agents
Chao Wang, Lingyu Shi, Shanbo Yang, et al.
Frontiers in Chemistry (2023) Vol. 11
Open Access | Times Cited: 1

Xanthatin and 8-epi-xanthatin as new potential colchicine binding site inhibitors: a computational study
Daniel Alpízar-Pedraza, Ania de la Nuez Veulens, Yoanna M. Álvarez Ginarte, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1

Xanthatin and 8-epi-xanthatin as new potential colchicine binding site inhibitors: a computational study
Daniel Alpízar-Pedraza, Ania de la Nuez Veulens, Yoanna M. Álvarez Ginarte, et al.
Journal of Molecular Modeling (2023) Vol. 29, Iss. 2
Open Access

Design, synthesis, and anti-breast tumor activity of novel combretastatin A-4 analogues
Yiting Gao, Jinfang Li, Teng Ma
Monatshefte für Chemie - Chemical Monthly (2023) Vol. 154, Iss. 11, pp. 1285-1294
Closed Access

Overcoming resistance in prostate cancer with targeted and small molecule-based therapies
Samantha Gogola, Michael Rejzer, Robert Poppiti
Elsevier eBooks (2023), pp. 255-287
Closed Access

Page 1

Scroll to top